The economic burden of RSV-associated illness in children aged < 5 years, South Africa 2011–2016

BACKGROUND: Data on the economic burden of RSV-associated illness will inform decisions on the programmatic implementation of maternal vaccines and monoclonal antibodies. We estimated the cost of RSV-associated illness in fine age bands to allow more accurate cost-effectiveness models to account for...

Descripción completa

Detalles Bibliográficos
Autores principales: Moyes, Jocelyn, Tempia, Stefano, Walaza, Sibongile, McMorrow, Meredith L., Treurnicht, Florette, Wolter, Nicole, von Gottberg, Anne, Kahn, Kathleen, Cohen, Adam L., Dawood, Halima, Variava, Ebrahim, Cohen, Cheryl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099882/
https://www.ncbi.nlm.nih.gov/pubmed/37055799
http://dx.doi.org/10.1186/s12916-023-02854-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099882/
https://www.ncbi.nlm.nih.gov/pubmed/37055799
http://dx.doi.org/10.1186/s12916-023-02854-2

Ejemplares similares